Diclofenac Gel Use in Children
Introduction to Diclofenac Gel
- The Pan-American League of Associations for Rheumatology (PANLAR) 2025 guidelines state that although diclofenac is not FDA or EMA approved for pediatric use, it can be considered at the discretion of the treating physician based on clinical experience in children with polyarticular JIA 1, 2
Regulatory Status and Evidence Base
- The American College of Rheumatology lists diclofenac among NSAIDs used at therapeutic dosing in juvenile idiopathic arthritis (JIA), though it is not specifically highlighted as a preferred agent 3
Preferred Alternatives in Pediatric Practice
- For children requiring NSAID therapy, naproxen is the preferred first-choice NSAID due to its evidence-supported efficacy and safety profile in pediatric populations, as recommended by guidelines from societies such as the American Academy of Pediatrics 4, 1, 2
- If naproxen is contraindicated or unavailable, alternative NSAIDs with FDA/EMA approval for pediatric use include: ibuprofen, indomethacin, meloxicam, tolmetin, etodolac, ketorolac, oxaprozin, and celecoxib, according to the American Academy of Pediatrics 4, 1, 2
Common Pitfalls to Avoid
- Do not use diclofenac gel as first-line therapy in children when evidence-based alternatives like naproxen or ibuprofen are available, as recommended by the American Academy of Pediatrics 4, 1, 2
- Acetylsalicylic acid (aspirin) should not be used in children with JIA despite FDA/EMA approval due to controversial efficacy, safety concerns, and toxicity risks, according to the American College of Rheumatology 1, 2
Breastfeeding Context
- Diclofenac is considered safe to use during breastfeeding, as small amounts are detected in breast milk and it has been used extensively during lactation, as stated by the World Health Organization 5
Diclofenac Sodium Gel Use in Adolescents
Key Licensing and Age Restrictions
- Diclofenac 3% gel in 2.5% hyaluronic acid is licensed specifically for adult patients with actinic keratosis, not for pediatric populations 6, 7
- The standard adult dosing for actinic keratosis is twice daily application for 60-90 days to the affected area 6, 7
- No pediatric studies exist for topical diclofenac gel, making its use in a 14-year-old off-label and unsupported by evidence 6, 7, 8, 9
Alternative Formulations for Adolescents
- Naproxen can be dosed at 5-7.5 mg/kg every 12 hours in adolescents, calculated based on body weight 10